CDC Advisory Committee on Immunization Practices (ACIP) Unanimously Votes to Provisionally Update Recommendations for Hepatitis A Vaccination

Dateline City:
KENILWORTH, N.J.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) voted to update multiple recommendations to protect against hepatitis A, which can be a serious liver disease caused by hepatitis A virus (HAV).

Language:
English

read more

Read Original Article: CDC Advisory Committee on Immunization Practices (ACIP) Unanimously Votes to Provisionally Update Recommendations for Hepatitis A Vaccination »